Ikarian Capital’s CervoMed CRVO Stock Holding History

Ikarian Capital’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-202,345	Closed	-$2.95M	–	185
2024 Q3	$2.95M	Sell	202,345 -35,000	-15%	-$542K	0.41%	63
2024 Q2	$4.06M	Hold	237,345	–	–	0.71%	35
2024 Q1	$5.53M	Buy	+237,345	New	+$3.17M	0.61%	53

Other funds holding CRVO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ikarian Capital's CRVO Position: Q4 2024 in Review

Ikarian Capital sold out of CervoMed (CRVO) in Q4 2024, closing a stake of 202,345 shares — an estimated $2.95M sold.

Ikarian Capital first reported a position in CRVO in Q1 2024 and held it in 3 quarters. The position peaked at $5.53M in Q1 2024. 49 funds tracked by Wall St. Rank hold CRVO as of Q4 2024.

Ikarian Capital reported no remaining CervoMed position as of Q4 2024 after selling out during the quarter.
Ikarian Capital sold 202,345 CervoMed shares in Q4 2024, an estimated $2.95M.
Ikarian Capital first reported a position in CervoMed in Q1 2024 and held it in 3 quarters.
Ikarian Capital's CervoMed position peaked at $5.53M in Q1 2024.
49 funds tracked by Wall St. Rank held CervoMed as of Q4 2024.

Based on Ikarian Capital's 13F filing for Q4 2024, filed 14 Feb 2025.